Does Mounjaro List Fatigue as a Side Effect?
Yes, fatigue is reported as a side effect of Mounjaro (tirzepatide), a GLP-1/GIP receptor agonist for type 2 diabetes and weight management. Clinical trials and post-marketing data show it affects 5-7% of users, typically mild and transient.[1][2]
How Common Is Fatigue and When Does It Happen?
In SURMOUNT trials for weight loss, fatigue occurred in 6.5% of patients on the 15 mg dose versus 2.5% on placebo. It often starts early in treatment, linked to rapid weight loss, calorie restriction, or dehydration from nausea/diarrhea. Most cases resolve within weeks as the body adjusts.[1][3]
Why Does Mounjaro Cause Fatigue?
Fatigue stems from:
- Gastrointestinal effects like nausea (up to 20% of users) reducing calorie intake.
- Blood sugar fluctuations or hypoglycemia risk in diabetics.
- Central nervous system impacts, including slower gastric emptying that affects energy levels.
Dehydration from vomiting exacerbates it; staying hydrated helps.[2][4]
What Do Patients Report About Fatigue?
User forums and reviews (e.g., Drugs.com, WebMD) frequently mention "extreme tiredness" or "daytime fatigue," especially in the first month. Some describe it as flu-like, improving after dose escalation pauses. Women report it more often, possibly tied to hormonal shifts.[5][6]
How to Manage or Reduce Fatigue on Mounjaro?
- Hydrate aggressively (2-3 liters water daily).
- Eat small, nutrient-dense meals to counter low calories.
- Start low (2.5 mg dose) and titrate slowly.
- Add electrolytes or B vitamins if deficient.
Consult a doctor before changes; severe fatigue warrants checking thyroid or anemia.[3][4]
When Should You Worry About Fatigue?
Seek medical help if fatigue persists beyond 4 weeks, worsens, or pairs with dizziness, confusion, or rapid heartbeat—these signal dehydration, electrolyte imbalance, or rare pancreatitis. It's not a reason to stop abruptly without advice.[2][7]
Does Fatigue Improve Over Time or Lead to Stopping?
Over 70% of fatigue cases resolve by week 12. Only 1-2% discontinue due to it in trials. Long-term users (1+ year) rarely report ongoing issues.[1][3]
[1]: FDA Mounjaro Label
[2]: Eli Lilly SURMOUNT-1 Trial Data
[3]: Drugs.com Mounjaro Side Effects
[4]: Mayo Clinic Tirzepatide Overview
[5]: WebMD User Reviews
[6]: Reddit r/Mounjaro Fatigue Threads
[7]: Healthline Mounjaro Warnings